Donald A. Fishbein
Consultant / Advisor at Visionary Venture Fund LP
Profile
Donald A.
Fishbein is currently a Limited Partner & Business Adviser at Visionary Venture Fund LP, an Advisor at Infocus Capital Partners, and an Advisor at Know Healthtech, Inc. He previously worked as a Director-Market Planning at Wyeth LLC from 1991 to 1995, a Marketing Manager at Genentech, Inc. from 1987 to 1990, a Senior Market Research Analyst at McNeil Pharmaceutical from 1984 to 1987, a Marketing & Financial Analyst at Smithkline Clinical Laboratories from 1980 to 1984, a VP-Marketing & Corporate Product Planning at Savient Pharmaceuticals, Inc. from 2004 to 2006, a Director at Strategyx LLC from 2006 to 2007, a Vice President-Commercial Operations at Aton Pharma, Inc. from 2007 to 2010, a VP & General Manager, Valeant Ophthalmic Division at Bausch Health US LLC from 2010 to 2014, and a Principal at GlaxoSmithKline, Inc. He also worked as a Consultant at Fishbein & Associates Performance Consulting from 2004 to 2006.
Mr. Fishbein received his undergraduate degree from George Washington University in 1976 and his MBA degree from The Wharton School of the University of Pennsylvania in 1980.
Donald A. Fishbein active positions
Companies | Position | Start |
---|---|---|
Visionary Venture Fund LP
Visionary Venture Fund LP Investment ManagersFinance Visionary Venture Fund LP invests in companies located in the US. The fund targets companies operating in the fields of healthcare. It provides financing for seed, early and later stage capital requirements with an investment size of $0.25 million to $10 million. | Consultant / Advisor | - |
Know Healthtech, Inc. | Consultant / Advisor | - |
Infocus Capital Partners
Infocus Capital Partners Investment ManagersFinance InFocus Capital Partners (InFocus Capital Partners) is a venture capital firm founded in 2016 by Rob Rothman and Ron Weiss. The firm is headquartered in Jericho, New York. | Consultant / Advisor | - |
Former positions of Donald A. Fishbein
Companies | Position | End |
---|---|---|
Bausch Health US LLC
Bausch Health US LLC Pharmaceuticals: MajorHealth Technology Bausch Health US LLC engages in the development, manufacture and market of pharmaceutical products. It specializes in therapeutic areas of neurology, dermatology, and infectious diseases. The company was founded in 2001 and is headquartered in Raleigh, NC. | Corporate Officer/Principal | 2014-03-31 |
Aton Pharma, Inc.
Aton Pharma, Inc. Pharmaceuticals: MajorHealth Technology Aton Pharma, Inc. develops therapeutics for cancer and other diseases. Its products include Edecrin, Sodium Edecrin, Cuprimine, Demser and Syprine. The company was founded by Michael G. Wells in 2001 and is headquartered in Lawrenceville, NJ. | Chief Operating Officer | 2009-04-28 |
Strategyx LLC | Director/Board Member | 2007-03-31 |
SAVIENT PHARMACEUTICALS INC | Sales & Marketing | 2006-08-31 |
Fishbein & Associates Performance Consulting | Consultant / Advisor | 2006-08-31 |
Training of Donald A. Fishbein
George Washington University | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 13 |
---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Savient Pharmaceuticals, Inc.
Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Aton Pharma, Inc.
Aton Pharma, Inc. Pharmaceuticals: MajorHealth Technology Aton Pharma, Inc. develops therapeutics for cancer and other diseases. Its products include Edecrin, Sodium Edecrin, Cuprimine, Demser and Syprine. The company was founded by Michael G. Wells in 2001 and is headquartered in Lawrenceville, NJ. | Health Technology |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
Smithkline Clinical Laboratories | |
McNeil Pharmaceutical | |
Strategyx LLC | |
Bausch Health US LLC
Bausch Health US LLC Pharmaceuticals: MajorHealth Technology Bausch Health US LLC engages in the development, manufacture and market of pharmaceutical products. It specializes in therapeutic areas of neurology, dermatology, and infectious diseases. The company was founded in 2001 and is headquartered in Raleigh, NC. | Health Technology |
Visionary Venture Fund LP
Visionary Venture Fund LP Investment ManagersFinance Visionary Venture Fund LP invests in companies located in the US. The fund targets companies operating in the fields of healthcare. It provides financing for seed, early and later stage capital requirements with an investment size of $0.25 million to $10 million. | Finance |
Infocus Capital Partners
Infocus Capital Partners Investment ManagersFinance InFocus Capital Partners (InFocus Capital Partners) is a venture capital firm founded in 2016 by Rob Rothman and Ron Weiss. The firm is headquartered in Jericho, New York. | Finance |
Fishbein & Associates Performance Consulting | |
Know Healthtech, Inc. |
- Stock Market
- Insiders
- Donald A. Fishbein